Tian‐Jian Yu
- Cancer Research top 5%
- Breast Cancer Treatment Studies 5
- Cancer, Hypoxia, and Metabolism 4
- Cancer, Lipids, and Metabolism 2
- Oncology top 10%
- Cancer Cells and Metastasis 4
-
- Immune cells in cancer 2
-
- Epigenetics and DNA Methylation 2
- RNA modifications and cancer 2
-
- Breast Lesions and Carcinomas 3
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- Nature Communications (1 paper)SHILAP Revista de lepidopterología (1 paper)Cell Metabolism (2 papers)
- Partner nations
- ChinaLaosUnited States
In The Last Decade
Tian‐Jian Yu
17 papers receiving 915 citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Cancer Research 442
- Oncology 296
- Immunology 207
- Molecular Biology 533
- Pulmonary and Respiratory Medicine 151
Countries citing papers authored by Tian‐Jian Yu
This map shows the geographic impact of Tian‐Jian Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tian‐Jian Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tian‐Jian Yu more than expected).
Fields of papers citing papers by Tian‐Jian Yu
This network shows the impact of papers produced by Tian‐Jian Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tian‐Jian Yu. The network helps show where Tian‐Jian Yu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tian‐Jian Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 23 | |
| 3 | Emerging therapies in cancer metabolismbreakdown → | 2023 | 132 |
| 4 | 2022 | 60 | |
| 5 | 2021 | 32 | |
| 6 | 2021 | 84 | |
| 7 | 2020 | 10 | |
| 8 | Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targetsbreakdown → | 2020 | 296 |
| 9 | 2019 | 7 | |
| 10 | 2018 | 7 | |
| 11 | 2018 | 9 | |
| 12 | 2018 | 4 | |
| 13 | 2017 | 139 | |
| 14 | 2017 | 111 | |
| 15 | 2017 | 1 | |
| 16 | 2012 | 1 | |
| 17 | 2005 | 1 |
About Tian‐Jian Yu
Tian‐Jian Yu is a scholar working on Cancer Research, Biochemistry and Immunology, having authored 17 papers that have together received 919 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), Cancer Cells and Metastasis (4 papers), Breast Lesions and Carcinomas (3 papers), Epigenetics and DNA Methylation (2 papers), Cancer, Lipids, and Metabolism (2 papers), RNA modifications and cancer (2 papers) and Immune cells in cancer (2 papers). The work is most often cited by research in Cancer Research (442 citations), Oncology (296 citations) and Immunology (207 citations). Tian‐Jian Yu has collaborated with scholars based in China, Laos and United States. Frequent co-authors include Gen‐Hong Di, Yi‐Zhou Jiang, Yi Xiao, Ding Ma, Yue Gong, Da‐Qiang Li, Zhi‐Ming Shao, Yiping Wang, Ying Xu and Rui Ding. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and Cell Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.